🔓
Sign in as a Member to unlock the full view of HRTX. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
HRTX

Heron Therapeutics, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $186.4M

Heron Therapeutics is a specialty pharma company focused on acute-care pain management with minimal political engagement and no material government revenue dependence.

Next filing → your inbox
Govt Dependence
15/100
Regulatory Density
65/100
Lobbying Intensity
5/100
Political Signal
LOW

BusinessWhat HRTX does

Heron develops and commercializes innovative IV pain management and anesthesia products, primarily for hospital and surgical settings. Revenue derives from specialty pharmaceutical sales to healthcare systems and providers, with no significant Medicare/Medicaid or government contract exposure.

12 months past · 3 months futureHRTX activity timeline

$2$1$0 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $1.49 hi $0.27 lo $0.31 CONGRESS 6 INSIDERS 0 13F FUNDS 30 BILLS 30 D.E. Shaw & Co. · holds $4M · 2025-12-31Renaissance Technologies · - $2M · 2025-12-31D.E. Shaw & Co. · holds $2M · 2026-03-31Citadel Advisors · - $2M · 2025-12-31Renaissance Technologies · - $1M · 2026-03-31Two Sigma Investments · + $1M · 2025-12-31 HR.41 · passed_one · 2026-06-03HR.161 · floor · 2026-04-28HR.184 · reported · 2026-09-15HR.109 · committee · 2025-12-19 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
249 trading days · 0 congressional trades shown · 0 insider buys · 6 13F filings · 4 past bill actions · 5 upcoming markups

Lifetime Government AwardsHRTX federal contracts

HRTX doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding HRTX

$1.3M
Total HRTX held by tracked 13F funds
5
Funds with HRTX positions
AQR Capital Management $663K +142% 2026-06-30
Renaissance Technologies $492K holds 2026-09-30
Two Sigma Investments $114K -16% 2026-06-30
D.E. Shaw & Co. $51K -95% 2026-06-30
Citadel Advisors $20K -94% 2026-06-30

Congressional TradesWho in Congress is trading HRTX

2022-06-02 Ro Khanna D-California · house purchase $1,001 - $15,000
2022-06-02 Ro Khanna D-California · house Purchase $1,001 - $15,000
2021-09-28 Ro Khanna D-California · house purchase $1,001 - $15,000
2021-09-28 Ro Khanna D-California · house Purchase $1,001 - $15,000
2021-03-31 Ashley Hinson R-Iowa · house sale $1,001 - $15,000
2021-03-31 Ashley Hinson R-Iowa · house Sale $1,001 - $15,000
6+ trades on file · most recent 2022-06-10

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

22
option exercises · $156K
For HRTX, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting HRTXLive legislation impacting this stock

Political ProfileWhere HRTX sits in Washington

Heron has no active lobbying presence, zero politician trades, and no named legislative winners/losers. Stock movement driven by clinical trial data, FDA decisions, and commercial execution rather than political events.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Medicare drug price negotiation expansion
  • FDA approval delays

Regulatory opportunities

  • Expedited approval pathways (Breakthrough Therapy)
  • Orphan drug incentives
Member intelligence layer

Live signals + predictions for HRTX — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout HRTX & political exposure

Does Heron Therapeutics, Inc. (HRTX) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Heron Therapeutics, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded HRTX stock?
6 congressional trades by 2 unique members of Congress, most recently on 2022-06-02. See the Congressional Trading panel for politician-by-politician breakdown.
What is HRTX political risk profile?
Government dependence: 15/100. Lobbying intensity: 5/100. Political signal: low.
How does GovGreed track HRTX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. HRTX data is updated daily from these official federal sources.